AMTX:NSD-Aemetis Inc (USD)

EQUITY | Specialty Chemicals | NASDAQ Global Market

Last Closing

USD 1.71

Change

0.00 (0.00)%

Market Cap

USD 0.04B

Volume

0.71M

Analyst Target

USD 4.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Aemetis Inc is a renewable fuels and biochemical company. It is engaged in the production of fuels and chemicals through acquisition, development and commercialization of technologies.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-01 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
LIN Linde plc Ordinary Shares

+7.25 (+1.56%)

USD 215.48B
BCPC Balchem Corporation

+0.96 (+0.58%)

USD 5.28B
WDFC WD-40 Company

+4.11 (+1.71%)

USD 3.30B
HWKN Hawkins Inc

+0.52 (+0.39%)

USD 2.78B
IOSP Innospec Inc

+1.56 (+1.83%)

USD 2.27B
CLMT Calumet Specialty Products Par..

-0.15 (-1.12%)

USD 1.07B
GEVO Gevo Inc

+0.03 (+2.59%)

USD 0.31B
HDSN Hudson Technologies Inc

+0.15 (+2.04%)

USD 0.31B
MNTK Montauk Renewables Inc

+0.15 (+8.62%)

USD 0.27B
LWLG Lightwave Logic Inc

+0.06 (+6.17%)

USD 0.12B

ETFs Containing AMTX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -36.43% 57% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.43% 57% F 19% F
Trailing 12 Months  
Capital Gain -50.43% 52% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -50.43% 52% F 19% F
Trailing 5 Years  
Capital Gain 111.16% 69% C- 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 111.16% 69% C- 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 100.44% 100% F 93% A
Dividend Return 100.44% 100% F 93% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 317.63% 33% F 8% B-
Risk Adjusted Return 31.62% 100% F 67% D+
Market Capitalization 0.04B 52% F 38% F

Key Financial Ratios

  Ratio vs. Industry/Classification (Specialty Chemicals) Ratio vs. Market (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio -2.88 71% 72%
Price/Free Cash Flow Ratio -8.77 95% 91%
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital -38.96% 22% 25%
Return on Assets -11.99% 39% 32%
Debt to Equity Ratio -93.79% 80% 92%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector